251 related articles for article (PubMed ID: 15239791)
21. Expression of c-kit receptor in normal and transformed human nonlymphoid tissues.
Natali PG; Nicotra MR; Sures I; Santoro E; Bigotti A; Ullrich A
Cancer Res; 1992 Nov; 52(22):6139-43. PubMed ID: 1384954
[TBL] [Abstract][Full Text] [Related]
22. Localization of thrombospondin and its cysteine-serine-valine-threonine-cysteine-glycine-specific receptor in human breast carcinoma.
Tuszynski GP; Nicosia RF
Lab Invest; 1994 Feb; 70(2):228-33. PubMed ID: 7511188
[TBL] [Abstract][Full Text] [Related]
23. KIT/stem cell factor expression in premalignant and malignant lesions of the colon mucosa in relationship to disease progression and outcomes.
Bellone G; Smirne C; Carbone A; Buffolino A; Scirelli T; Prati A; Solerio D; Pirisi M; Valente G; Nano M; Emanuelli G
Int J Oncol; 2006 Oct; 29(4):851-9. PubMed ID: 16964380
[TBL] [Abstract][Full Text] [Related]
24. MnSOD expression is less frequent in tumour cells of invasive breast carcinomas than in in situ carcinomas or non-neoplastic breast epithelial cells.
Soini Y; Vakkala M; Kahlos K; Pääkkö P; Kinnula V
J Pathol; 2001 Sep; 195(2):156-62. PubMed ID: 11592093
[TBL] [Abstract][Full Text] [Related]
25. C-kit expression in high-risk breast cancer subgroup treated with high-dose or conventional dose-dense chemotherapy.
Diallo R; Ting E; Gluz O; Herr A; Schütt G; Geddert H; Mohrmann S; Gabbert HE; Nitz U; Poremba C
Verh Dtsch Ges Pathol; 2006; 90():177-85. PubMed ID: 17867595
[TBL] [Abstract][Full Text] [Related]
26. KIT protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma.
Holst VA; Marshall CE; Moskaluk CA; Frierson HF
Mod Pathol; 1999 Oct; 12(10):956-60. PubMed ID: 10530560
[TBL] [Abstract][Full Text] [Related]
27. Evidence for a functional kit receptor in melanoma, breast, and lung carcinoma cells.
DiPaola RS; Kuczynski WI; Onodera K; Ratajczak MZ; Hijiya N; Moore J; Gewirtz AM
Cancer Gene Ther; 1997; 4(3):176-82. PubMed ID: 9171936
[TBL] [Abstract][Full Text] [Related]
28. Malignant phyllodes tumours show stromal overexpression of c-myc and c-kit.
Sawyer EJ; Poulsom R; Hunt FT; Jeffery R; Elia G; Ellis IO; Ellis P; Tomlinson IP; Hanby AM
J Pathol; 2003 May; 200(1):59-64. PubMed ID: 12692842
[TBL] [Abstract][Full Text] [Related]
29. The spectrum of 67-kD laminin receptor expression in breast carcinoma progression.
Viacava P; Naccarato AG; Collecchi P; Ménard S; Castronovo V; Bevilacqua G
J Pathol; 1997 May; 182(1):36-44. PubMed ID: 9227340
[TBL] [Abstract][Full Text] [Related]
30. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
Bircan S; Kapucuoglu N; Baspinar S; Inan G; Candir O
Pathol Res Pract; 2006; 202(8):569-76. PubMed ID: 16828238
[TBL] [Abstract][Full Text] [Related]
31. IL-6, its receptors and its relationship with bcl-2 and bax proteins in infiltrating and in situ human breast carcinoma.
Garcia-Tuñón I; Ricote M; Ruiz A; Fraile B; Paniagua R; Royuela M
Histopathology; 2005 Jul; 47(1):82-9. PubMed ID: 15982327
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical expression of human erythrocyte glucose transporter and fatty acid synthase in infiltrating breast carcinomas and adjacent typical/atypical hyperplastic or normal breast tissue.
Alò PL; Visca P; Botti C; Galati GM; Sebastiani V; Andreano T; Di Tondo U; Pizer ES
Am J Clin Pathol; 2001 Jul; 116(1):129-34. PubMed ID: 11447743
[TBL] [Abstract][Full Text] [Related]
33. Elevated expression of the myc gene in human benign and malignant breast lesions compared to normal tissue.
Spandidos DA; Pintzas A; Kakkanas A; Yiagnisis M; Mahera H; Patra E; Agnantis NJ
Anticancer Res; 1987; 7(6):1299-304. PubMed ID: 3327455
[TBL] [Abstract][Full Text] [Related]
34. p27/kip1 expression in normal epithelium, benign and neoplastic breast lesions.
De Paola F; Vecci AM; Granato AM; Liverani M; Monti F; Innoceta AM; Gianni L; Saragoni L; Ricci M; Falcini F; Amadori D; Volpi A
J Pathol; 2002 Jan; 196(1):26-31. PubMed ID: 11748638
[TBL] [Abstract][Full Text] [Related]
35. Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancers.
Wilczynski SP; Chen YY; Chen W; Howell SB; Shively JE; Alberts DS
Hum Pathol; 2005 Mar; 36(3):242-9. PubMed ID: 15791568
[TBL] [Abstract][Full Text] [Related]
36. Expression of c-kit and platelet-derived growth factor receptors in ovarian granulosa cell tumors.
Rocconi RP; Matthews KS; Kimball KJ; Conner MG; Baker AC; Barnes MN
Reprod Sci; 2008 Sep; 15(7):673-7. PubMed ID: 18492696
[TBL] [Abstract][Full Text] [Related]
37. Expression of KIT, EGFR, HER-2 and tyrosine phosphorylation in undifferentiated thyroid carcinoma: implication for a new therapeutic approach.
Murakawa T; Tsuda H; Tanimoto T; Tanabe T; Kitahara S; Matsubara O
Pathol Int; 2005 Dec; 55(12):757-65. PubMed ID: 16287490
[TBL] [Abstract][Full Text] [Related]
38. RET finger protein expression in invasive breast carcinoma: relationship between RFP and ErbB2 expression.
Tezel GG; Uner A; Yildiz I; Guler G; Takahashi M
Pathol Res Pract; 2009; 205(6):403-8. PubMed ID: 19232840
[TBL] [Abstract][Full Text] [Related]
39. Expression of the 21,000 molecular weight ras protein in a spectrum of benign and malignant human mammary tissues.
Ohuchi N; Thor A; Page DL; Hand PH; Halter SA; Schlom J
Cancer Res; 1986 May; 46(5):2511-9. PubMed ID: 3084069
[TBL] [Abstract][Full Text] [Related]
40. HMGA1 protein overexpression in human breast carcinomas: correlation with ErbB2 expression.
Chiappetta G; Botti G; Monaco M; Pasquinelli R; Pentimalli F; Di Bonito M; D'Aiuto G; Fedele M; Iuliano R; Palmieri EA; Pierantoni GM; Giancotti V; Fusco A
Clin Cancer Res; 2004 Nov; 10(22):7637-44. PubMed ID: 15569996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
